Background and ObjectivesImmunosuppressive multiple sclerosis (MS) disease-modifying therapies (DMTs) may increase the risk of opportunistic infections such as herpes zoster (HZ). We sought to evaluate the risk of HZ across various MS DMTs using publicly …
In 2009, treatment-resistant obsessive compulsive disorder (OCD) was approved as an indication for deep brain stimulation (DBS) under a Humanitarian Device E…
Salary: $225,000 – $260,000 We are seeking a BE/BC Pediatric Neurologist to join the growing department of Pediatrics at The Brooklyn Hospital Cent…
This intensive course, developed by the International Society for Stem Cell Research (ISSCR), offers a comprehensive exploration of key topics in stem cell medicine. Designed…
IntroductionFocal lesions such as a stroke can cause not only local effects but also distant effects in anatomically intact regions. The impact of stroke les…
Ibudilast (IBD) is a new drug that has been released as treatment for multiple sclerosis (MS). Retinoic acid (RA), a metabolite of vitamin A, is…
IntroductionSpinal cord injury (SCI) remains a debilitating condition with limited therapeutic options. Exploring hypoxia-related genes in SCI may reveal pot…
Background and ObjectivesInfections are associated with an increased risk of relapse and pseudo-relapse in persons with multiple sclerosis (MS). However, the relationship with relapses and…
Nature Neuroscience – Noel et al. show aberrant updating of expectations in three distinct mouse models of autism spectrum disorder. Brain-wide neurophysiology data suggest this…
The American Academy of Neurology’s Capitol Hill Report is a bi-weekly update on legislative and regulatory advocacy for neurology. Read the latest report.
On the cover, paint splotches in diverse hues represent glial cells (microglia in green and blue, astrocytes in yellow, oligodendrocytes along with myelin in…
